# Cannabidiol for Pain Relief of Patients With End-stage mCRPC

> **NCT07549256** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Regionshospital Nordjylland** · enrollment: 58 (estimated)

## Conditions studied

- Metastatic Castration Resistant Prostate Cancer (mCRPC)

## Interventions

- **DRUG:** Cannabidiol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07549256
- **Lead sponsor:** Regionshospital Nordjylland
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-05-31
- **Final completion:** 2029-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07549256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07549256, "Cannabidiol for Pain Relief of Patients With End-stage mCRPC". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07549256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*